Disc Medicine, Inc. — Investor Relations & Filings
Filings indexed
690
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
IRON
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients with serious hematologic diseases. The company's research focuses on fundamental pathways of red blood cell biology to address a range of disorders. Its pipeline includes bitopertin, an investigational therapy for erythropoietic protoporphyria (EPP) for which a New Drug Application has been submitted for accelerated approval. Other clinical-stage programs are evaluating treatments for myelofibrosis-associated anemia and other conditions involving ineffective erythropoiesis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | |
| 8-K - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | |
| ARS - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | |
| DEF 14A - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | |
| 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-03-04 | English | |
| 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41373791 | 10-Q - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | ||
| 41373680 | 8-K - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | ||
| 38193714 | ARS - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | ||
| 38179519 | DEF 14A - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | ||
| 32898845 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-03-04 | English | ||
| 32898846 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English | ||
| 32898848 | 8-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English | ||
| 32898851 | 10-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-26 | English | ||
| 32898849 | 8-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-26 | English | ||
| 32898847 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-19 | English | ||
| 31848965 | 4 Filing | 2026-02-17 | English | ||
| 31848958 | 4 Filing | 2026-02-17 | English | ||
| 31848947 | 4 Filing | 2026-02-17 | English | ||
| 31848932 | 4 Filing | 2026-02-17 | English | ||
| 31848902 | 4 Filing | 2026-02-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
Disc Medicine, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31589/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31589 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31589 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31589 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31589}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Disc Medicine, Inc. (id: 31589)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.